NewAmsterdam Pharma Company N.V. (NAMSW)

SEC filing

NewAmsterdam Pharma Company N.V.

NAMSW · CIK 1936258

4 · Aug 25, 2026 · Director, Chief Scientific Officer Kastelein Johannes Jacob Pieter sold 125K shares at $26.91/share ($3.4M); exercised options for 250K shares

Director, Chief Scientific Officer Kastelein Johannes Jacob Pieter sold 125K shares at $26.91/share ($3.4M); exercised options for 250K shares

Filed: Aug 25, 2026
Accession: 0001193125-26-365202
Filer: NewAmsterdam Pharma Co N.V.

View on SEC.gov All SEC filings

Could not load the primary document from EDGAR (SEC rate limit, timeout, or temporary upstream error). Refresh in a minute, or use View on SEC.gov.